Showing results (111-120 of 250) with videos related to
Sort By:
Pageof 25
Lung Cancer (Amsterdam, Netherlands)|June 27, 2003
Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology GroupDimosthenis-Vasilios Skarlos, Athanassios-Meletios Dimopoulos, Paraskevas Kosmidis, et al.Cancer Medicine|December 10, 2015
Intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence: meta-analysis of three trialsAgnieszka Malczewski, Andrea Marshall, Miranda J Payne, et al.Cancer Treatment Reviews|July 6, 2026
Neoadjuvant and adjuvant therapy in uveal melanoma: toward systemic control of a systemic diseaseDimitra Foteinou, Charalampos Theocharopoulos, Dimitrios Ν Varvoglis, et al.Melanoma Research|September 28, 2011
Insulin resistance in relation to melanoma riskAntonios G Antoniadis, Eleni Th Petridou, Constantine N Antonopoulos, et al.Critical Reviews in Oncology/Hematology|March 23, 2017
Mucosal melanoma of the head and neckPaolo Antonio Ascierto, Remo Accorona, Gerardo Botti, et al.Clinical Breast Cancer|May 26, 2010
Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology GroupHelen Gogas, Dimitrios Pectasides, Ioannis Kostopoulos, et al.Anticancer Research|April 20, 2006
Expression of p27KIP1, p21WAF1 and p53 does not correlate with prognosis in node-negative invasive ductal carcinoma of the breastHelen P Kourea, Angelos K Koutras, Vassiliki Zolota, et al.Experimental Dermatology|July 19, 2008
A study of a single variant allele (rs1426654) of the pigmentation-related gene SLC24A5 in Greek subjectsGerasimos Dimisianos, Irene Stefanaki, Vicky Nicolaou, et al.Journal for Immunotherapy of Cancer|March 31, 2021
Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB-IVM1c melanomaJosep Malvehy, Igor Samoylenko, Dirk Schadendorf, et al.American Journal of Therapeutics|January 14, 2014
Treatment algorithms in stage IV melanomaEnrique Espinosa, Jean-Jacques Grob, Reinhard Dummer, et al.Pageof 25